[Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].

Lin Liu, Yingzi Tang, Jungang Li, Jijun Zhou, Xiaohong Wang, Yuming WangPubMed 2010 · DOI

Abstract

Quasispecies composition of HBV is closely correlated with nucleotide analog susceptibility. ETV resistant variant can emerge from a LAM resistant viral population. Dynamic monitoring of HBV quasispecies composition is of great importance during nucleotide analog therapy.
BibTeX
@inproceedings{liu2010evolution,
  author = {Lin Liu and Yingzi Tang and Jungang Li and Jijun Zhou and Xiaohong Wang and Yuming Wang},
  title = {{[Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].}},
  booktitle = {PubMed},
  year = {2010},
  doi = {10.3760/cma.j.issn.1007-3418.2010.06.007},
}

Loading related content...

Figure